RASECAL-Bronchoscopic Ambusampler
Rasecal
A Randomized Controlled Trial to Assess the Safety and Efficiency of a Self-Contained Sampling Device /disposable Bronchoscope System Versus Usual SampLing Procedure.
1 other identifier
observational
207
1 country
1
Brief Summary
Prospective, multi-centre, open labelled, 1:1randomized controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2022
CompletedFirst Submitted
Initial submission to the registry
April 18, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2024
CompletedDecember 10, 2024
December 1, 2024
2.7 years
April 18, 2023
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of two sampling pots
Can the Ambu Bronchosampler improve safety versus usual standard care by reducing the risk of spillage or disconnection of the sampling system during a procedure?
1month
Eligibility Criteria
Patients requiring clinical bronchoscopy
You may qualify if:
- (All are required)
- Clinicians experienced in performing bronchoscopies (i.e. bronchoscopists should have performed a minimum 5 bronchoscopies in mechanically ventilated patients and a minimum of 5 bronchoscopies in a simulated or practice setting).
- Clinicians who have undergone the online product-training module for the use of the Ambu Bronchosampler, with self-certification documented.
- Clinicians who have simulated the online product training module using an Ambu Bronchosampler and Ambu Ascope4 a minimum of 5 times in a practice setting and have self-certified.
- Population
- Patients ≥ 18 years old
- Patients on mechanical ventilation with Acute respiratory failure for \>4h
- Patients eligible for a clinically indicated bronchoscopy with fluid sampling. Patient information has been explained and verbal or written consent has been obtained
You may not qualify if:
- Investigators
- Investigators who have not completed product training in aScope BronchoSampler by online and hands-on from Ambu product specialists or an experienced user from the site.
- Investigators with experience in \< 5 self-verified simulated fluid sampling procedures using the Ambu BronchoSampler 4.8.2 Population
- Clinician concern regarding safety of bronchoscopy
- Involved study personal not available to perform the procedure and enroll the patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chelsea and Westminster Hospital NHSFT
London, SW10 0XD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Damon 0 Foster, 0
Chelsea and Westminster NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2023
First Posted
July 27, 2023
Study Start
January 14, 2022
Primary Completion
October 10, 2024
Study Completion
October 10, 2024
Last Updated
December 10, 2024
Record last verified: 2024-12